Navigation Links
Diplomat Specialty Pharmacy Hires National Accounts Director To Expand Kidney Disease Services
Date:4/8/2008

SWARTZ CREEK, Mich., April 8, 2008 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced Mike Maynard has joined the company as Director of National Accounts. Maynard reports directly to Dr. Atheer Kaddis, Vice President of Managed Markets.

Maynard is responsible for the development and national expansion of Diplomat's disease management programs, focusing initially on chronic kidney disease, dialysis, and renal transplant. Diplomat's disease management programs, through direct patient contact and coordination with physicians, improve access, tolerance, and compliance to appropriate medication therapy resulting in improved patient outcomes.

"Diplomat Specialty Pharmacy is very excited to welcome Mike Maynard to our team," said Kaddis. "He will lead our efforts in working with providers, employer groups and managed care organizations to further expand our best in class disease management programs focusing on chronic kidney disease, dialysis, and renal transplant. Mike will help Diplomat become a national leader in caring for patients with kidney disease."

"After spending many years in the renal marketplace, I am very excited to join the team at Diplomat Specialty Pharmacy," said Maynard. "Disease Management programs and initiatives can stem progression of disease, improve medication adherence, control costs and improve quality of life. Diplomat's CKD Navigator Program, as well as the Dialysis and Transplant Programs, are the most comprehensive and innovative programs available. I look forward to being a part of the great things that are happening at Diplomat Specialty Pharmacy."

Maynard's fifteen years as an executive in the pharmaceutical industry include extensive experience in sales, sales management and training, and Regional and National Account Management. Immediately before joining Diplomat Specialty Pharmacy, he served as an Integrated Delivery Network/Renal Account Manager with Roche Pharmaceuticals. In addition, he has over eight years of experience in the renal marketplace with Sigma-Tau Pharmaceuticals, and brings extensive experience in contract negotiation, and developing and implementing sales/marketing strategies with dialysis providers and renal Group Purchasing Organizations. Maynard holds a Bachelor of Business Administration degree from Western Michigan University, Kalamazoo, MI.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns

kkarns@diplomatpharmacy.com

810-720-4452


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Health Plans Employ Various Strategies to Combat Cost of Specialty Drugs
2. American Specialty Health and INSPIRIS Win Top Honors in URACs Best Practices in Consumer Empowerment and Protection Awards
3. Zero Patient Infections Reported as D.I.S.C. Spine and Sports Center Sets New Standard for Specialty Hospitals
4. EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
5. MHA Announces Initial Results of the Specialty Pharmacy Member Profile Initiative
6. Specialty Underwriters Alliance, Inc. Reports 2007 Fourth Quarter and Full Year Results
7. Relax The Back Announces Record Growth in 2007; Executives Bullish on Specialty Retailers Prospects for 2008
8. Specialty European Pharma launches plenaxis in Germany
9. Darwin Enters into Marketing Partnership with Agency Specialty Product Network
10. MarketResearch.com Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market
11. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. ... Mediaplanet, Dr. Murthy explains how he was inspired to practice medicine at an early ... medicine is about more than making diagnoses and prescribing medicine,” he states. “It is ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... ... , ... More than half of American teens report losing their virginity before ... their child about sex related topics, less than 60 percent spoke about deeper themes ... the launch of its second edition of the “Sexual Wellness” campaign, aiming to address ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, ... entry through labeling, storing, shipping and disposal. The new version is a faster ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical Systems, Inc. ... the first company to offer robotic imaging to veterinary medicine is sponsoring the ... 941 for the American Association of Equine Practitioners 62nd Annual Convention from December ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... December 2, 2016 Orthopedic Implants (Including ... is Expected to Gain a Significant Market Share Owing to ... ... According to a new report ... Implants Sterile Packaging: Clamshell Product Type Segment Projected to Witness ...
(Date:12/2/2016)... Dec. 2, 2016   CytoSorbents Corporation (NASDAQ: ... its European Union approved CytoSorb ® cytokine adsorber ... patients worldwide, announced that Dr. Phillip Chan , ... Annual LD Micro Main Event investor conference held ... the Luxe Sunset Boulevard Hotel in Los ...
(Date:12/2/2016)... 2, 2016 On Thursday, the NASDAQ ... Dow Jones Industrial Average edged 0.36% higher, to finish at ... Losses were broad based as six out of nine sectors ... reports on the following Services equities: Myriad Genetics Inc. (NASDAQ: ... ), INC Research Holdings Inc. (NASDAQ: INCR ), ...
Breaking Medicine Technology: